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Abstract T-2 toxin is a mycotoxin produced by some
Fusarium species, which may affect the synthesis of DNA
and RNA and causes various pathological processes. Till
now, the influence of T-2 toxin on the enteric nervous
system (ENS) located in the wall of gastrointestinal tract
has not been studied. On the other hand, cocaine- and
amphetamine-regulated transcript (CART) is one of enteric
neuronal factors, whose exact functions in the intestines
still remain not fully explained. The present study describes
the influence of low doses of T-2 toxin on CART-positive
neuronal structures in porcine stomach, duodenum, and
descending colon. Distribution of CART was studied using
the double immunofluorescence technique in the plexuses
of the ENS, as well as in nerve fibers within the circular
muscle and mucosal layers of porcine gastrointestinal tract.
Generally, after T-2 toxin administration the greater num-
ber of CART-LI structures were studied, but intensity of
changes depended on part of the ENS and digestive tract
fragment studied. The obtained results show that even low
doses of T-2 toxin may change the expression of CART in
the ENS.
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Introduction
Mycotoxins, naturally produced by some representatives of
the fungi kingdom, are very numerous and differential
group of substances, which often can contaminate the food
and may have negative impact on living organisms. One of
the mycotoxins that is important for the human and animal
health situation is T-2 toxin, structurally belonging to
chemical substances called trichothecenes (Fig. 1), which
are characterized by a tetracyclic sesquiterpenoid ring
system (Marin et al. 2013). This substance is synthetized
by some Fusarium species (primarily by F. sporotri-
chioides, F. langsethiae, F. acuminatum, and F. poae) and
it has been described in all most often cultivated over the
world cereal species, such as wheat, oats, barley, and corn,
as well as in foodstuffs produced from the above-men-
tioned grains (De Ruyck et al. 2015). Till now, various
types of negative influence of T-2 toxin on living organ-
isms have been described. First of all, longer exposition to
this toxin can contribute to the development of alimentary
toxic aleukia (ATA), which is characterized by various
intestinal and general symptoms including vomiting, nau-
sea, diarrhea, leukopenia, high fever, as well as inflam-
matory processes within the skin and in some cases leading
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Moreover, T-2 toxin is known as the factor, which can
influence on functions of thymus, spleen, and, on grounds
of the ability to the crossing of blood–brain barrier, on
nervous system (Martin et al. 1986; Doi and Uetsuka 2011;
Weidner et al. 2013; Agrawal et al. 2015). At the cellular
scale, T-2 toxin activity relies on the damage of mito-
chondria, inhibition of DNA and RNA synthesis, as well as
suppression of apoptosis (Marin et al. 2013; De Ruyck
et al. 2015).
In spite of the relatively well-known results of T-2 toxin
poisoning, many aspects of its actions (especially in low
doses) are completely unknown. One of them is the influ-
ence on the enteric nervous system (ENS), which is located
in the wall of the digestive tract and on the grounds of
complex building, high number of neurons and consider-
able independence from the central nervous system is often
called the ‘‘second’’ or ‘‘intestinal brain’’ (Furness et al.
2014). In big mammals, the anatomy of the ENS depends
on the segment of digestive tract (Fig. 2). Namely, in the
stomach it consists of two intramural ganglionated plexu-
ses: myenteric plexus (MP) located between longitudinal
and circular muscular layers and submucous plexus (SP)—
near the lamina propria of the mucosa. In the small and
large intestine, submucous plexus undergoes a division to
outer submucous plexus (OSP) located near internal side of
the circular muscle layer and inner submucous plexus
(ISP)—positioned in the same place like submucous plexus
in the stomach (Gonkowski 2013; Bulc et al. 2015; Reka-
wek et al. 2015).
It is known that ENS responds to various pathological
factors, including inflammatory processes, bacterial infec-
tions, toxins, and extra-intestinal diseases by structural,
functional, and neurochemical changes (Vasina et al.
2006). The most visible are fluctuations in the expression
of neuromediators and/or neuromodulators, which manifest
adaptive and/or neuroprotective processes within enteric
neurons under acting stimuli (Gonkowski et al. 2003;
Vasina et al. 2006; Gonkowski 2013).
One of several dozen neuronal active substances, which
till now have been described in the ENS, is cocaine- and
amphetamine-regulated transcript peptide (CART). For the
first time, CART was described in 1981 (Spiess et al. 1981)
and since then it has been noted in the ENS of many
species, including human (Ellis and Mawe 2003; Ekblad
2006; Arciszewski et al. 2009; Gonkowski et al. 2012; Bulc
et al. 2014). Nonetheless, exact functions of this peptide in
the gastrointestinal tract both in physiological conditions
and during pathological processes are still controversial
and not fully explained.
So, the aim of this study was to describe for the first time
the influence of low doses (suggested permissible level in
feed for farming animals) of T-2 toxin on CART-like
immunoreactivity within the ENS of selected parts of
digestive tract in pig, which currently is considered to be an
optimal laboratory animal (much better then rodents) to
simulation of processes in the human gastrointestinal tract
due to anatomical and physiological resemblances in the
ENS between these two species (Verma et al. 2011).
Fig. 1 Scheme of the chemical structure of T-2 toxin molecule
Fig. 2 Scheme of the enteric
nervous system in the porcine
gastrointestinal tract. Elements
of the wall of GI tract: LM
longitudinal muscle layer, CM
circular muscle layer, SL
submucosal layer, ML mucosal
layer. Elements of the enteric
nervous system: MP myenteric
plexus, SP gastric submucous








Ten immature gilts (8 weeks of age, about 18 kg body
weight) of the large White polish breed were used during the
present experiment. The animals were divided into two
groups: control (C group) and experimental (T-2 group),
each of which consisted of five pigs. Control animals
received empty gelatin capsules, once daily before the
morning feeding for 42 days. In the event of experimental
pigs, capsules were filled with T-2 toxin with a dose of
200 lg/kg of feed (suggested permissible level in feed for
pig which was proposed as the lowest level by Eriksen and
Pettersson 2004). During experiment, animals were kept in
standard conditions, and all experimental actions were made
in accordance with instructions of Local Ethical Committee
for Animal Experiments in Olsztyn (Poland) (decision from
Nov 28, 2012, identification code 73/2012/DTN).
After experimental period, all pigs were euthanized using
an overdose of sodium thiopental (Thiopental, Sandoz,
Kundl-Raku´sko, Austria) and fragments of the stomach,
duodenum, and descending colon were collected immedi-
ately after death of animals. Tissues were sampled from the
selfsame fragments of particular segments of the gastroin-
testinal tract. In the case of stomach, the sample of 3 cm2
came from the ventral part of corpus, in the central line,
20 cm from the cardia. From intestines, samples (2 cm long)
were taken from duodenum (5 cm from the pylorus) and
descending colon (from the part contiguous with inferior
mesenteric ganglia). Immediately after collecting, samples
were fixed in a solution of 4 % buffered paraformaldehyde
(pH 7.4) for 1 h, rinsed in phosphate buffer (0.1 M, pH 7.4, at
4 C) for 3 days with the exchange of buffer every day, and
inserted into 18 % phosphate buffered sucrose (at 4 C) for
2 weeks. Then samples were frozen at -22 C, cut perpen-
dicular to the lumen of the GI tract into 14-lm-thick sections
using microtome (Microm, HM 525, Walldorf, Germany),
and fixed on glass slides.
Immunofluorescence Procedure
The slices of stomach and intestine were examined using
standard double-labeling immunofluorescence technique
that has been described previously by Wojtkiewicz et al.
(2013). In short, it was as follows: after drying (45 min. at
room temperature) and incubation with blocking solution
containing 10 % goat serum, 0.1 % bovine serum albumin
(BSA), 0.01 % NaN3, Triton X-100, and thimerosal in
buffered NaCl solution (PBS) (1 h, room temp.), the
samples were treated with the combination of antisera
directed towards protein gene-product 9.5 (PGP 9.5; mouse
monoclonal, Biogenesis, UK, working dilution 1:1000,
used here as a pan neuronal marker) and CART (rabbit
monoclonal, Phoenix Pharmaceuticals, USA, 1:16,000) and
incubated overnight in a humidity chamber at room tem-
perature. Then probes were incubated with the combination
of species-specific secondary antibodies, i.e., Alexa fluor
488 donkey anti-mouse IgG and Alexa fluor 546 donkey
anti-rabbit IgG, both from Invitrogen, Carlsbad, CA, USA,
working dilution 1:1000 (1 h, room temp.). The rinsings of
probes in buffered NaCl solution (PBS, 0.1 mol, pH 7.4,
15 min 9 3) were made between each step of the above-
mentioned procedure.
Specificity of the labeling was verified by standard
control procedures, including pre-absorption, omission, and
replacement tests. The pre-absorption consisted in
replacement active primary antibodies by the same anti-
bodies, but pre-absorbed with native human protein gene-
product 9.5 (AbD Serotec, UK) and synthetic CART pep-
tide (Phoenix Pharmaceuticals, USA) at a concentration of
20 lg/ml for 18 h, at 37 C. These procedures eliminated
specific stainings.
Immunostained tissue slices were evaluated using
Olympus BX51 microscope equipped with epi-fluores-
cence and appropriate filter sets. To calculate the percent-
age of CART-like immunoreactive (CART-LI) neurons, at
least 500 cell bodies immunoreactive to PGP 9.5 in par-
ticular types of enteric plexuses (MP, OSP and ISP) in each
animal were evaluated in terms of CART-like immunore-
activity and only cells with well-visible nucleus were
considered during experiment. The obtained results were
presented as mean ± SEM.
Moreover, during the present study two methods were
used to define the density of CART-LI nerve fibers. In case
of intraganglionic nerve processes, the indication of this
value was based on arbitrary cautioning scale from (-) (the
absence of studied fibers) to (????) (very frequent sys-
tem of studied fibers). In contrast, CART-positive nerves in
the muscular and mucosal layers were evaluated per
observation field (0.1 mm2). Nerve fibers were counted in
four tissue sections per animal (in five field per section) and
the obtained data were pooled and presented as mean ±
SEM. To prevent double counting of neuronal cells and
nerve fibers, the evaluated sections of the GI tract were
located at least 150 lm apart. Statistical analysis was made
with Anova-test (Statistica 9.1, StatSoft, Inc.) and differ-
ences were considered statistically significant at p B 0.05.
Results
During the present study, CART-LI neuronal structures
have been noted in the enteric nervous system of the
stomach, duodenum, and descending colon in both control
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animals and in pigs after T-2 toxin administration. Their
number clearly depended on the ‘‘type’’ of enteric gan-
glion, as well as the segment of the GI tract studied
(Table 1).
In the stomach of control animals, the majority of
CART-positive neurons have been observed within
myenteric plexus, where such cells amounted to almost half
(46.24 ± 2.12 %) of all neurons immunoreactive to neu-
ronal marker—PGP 9.5 (Fig. 3Ia). They were accompanied
by single (?) intraganglionic nerves immunoreactive to
CART. In contrast, small percentage of CART-positive
neuronal cells (6.39 ± 0.17 % of all neurons) was inves-
tigated in the gastric submucous plexuses (Table 1).
Moreover, two ‘‘kinds’’ of ganglia in this plexus were
observed. The majority of them have no CART-LI neurons
(Fig. 3IIa), but in some submucosal ganglia even all neu-
rons were immunoreactive to this peptide (Fig. 3IIa1). The
density of intraganglionic CART-positive nerves in gastric
SP was similar to those observed in MP (?). Moreover,
under physiological conditions, a density network of
CART-positive nerves was observed within the gastric
muscular layer (an average of 13.36 ± 0.75 fibers per
observation field) (Fig. 4Ia), while in the mucosa of the
stomach only single such nerves was investigated
(0.83 ± 0.25 per observation field) (Fig. 5Ia).
The higher number of CART-positive enteric neurons in
intestinal fragment studied of control animals was observed
(like in the stomach) within myenteric plexus (Table 1).
Nonetheless, the percentage of these neurons was lower
than in the stomach and amounted to 38.10 ± 3.43 % in
duodenum (Fig. 6Ia) and 33.43 ± 3.39 % within
descending colon (Fig. 7Ia). Moreover, in MP of both
fragments of intestine a dense network (???) of intra-
ganglionic nerve processes immunoreactive to CART was
noted. In turn, the number of CART-LI neuronal cells
within submucosal plexus, which in the intestine is divided
into outer and inner submucous plexuses, was higher than
in the stomach. In duodenum, these values amounted to
28.70 ± 0.90 and 21.96 ± 1.85 % in the OSP and ISP,
respectively (Fig. 6IIa, IIIa). In descending colon, the
percentage of submucosal neurons immunoreactive to
CART was similar and came to 27.50 ± 1.07 % in the
OSP (Fig. 7IIa) and 19.07 ± 4.11 % in the ISP (Fig. 7
IIIa). In addition, in both ‘‘types’’ of submucosal plexuses
Table 1 CART peptide-like immunoreactive (CART-LI) perikarya
and nerve fibers in porcine stomach, duodenum, and descending colon
under physiological conditions (C group) and after T-2 toxin
administration (T2 group)
Stomach C group T2 group
CMLa 13.36 ± 0.75 20.25 ± 1.32
MP
CBb 46.24 ± 2.12 63.59 ± 1.12
NFc ? ??
SP
CBb 6.39 ± 0.17 16.33 ± 1.30
NFc ? ?
S/MLa 0.83 ± 0.25 2.92 ± 0.45
Duodenum
CMLa 15.99 ± 0.80 26.66 ± 1.73
MP
CBb 38.10 ± 3.43 63.80 ± 0.83
NFc ??? ???
OSP
CBb 28.70 ± 0.90 53.31 ± 1.49
NFc ?? ??
ISP
CBb 21.96 ± 1.85 35.86 ± 1.85
NFc ?? ???
S/ML 3.07 ± 0.14 8.3 ± 1.18
Descending colon
CMLa 15.33 ± 1.77 23.37 ± 1.04
MP
CBb 33.43 ± 3.39 47.16 ± 1.30
NFc ??? ???
OSP
CBb 27.50 ± 1.07 41.38 ± 1.79
NFc ?? ???
ISP
CBb 19.07 ± 4.11 42.35 ± 6.18
NFc ? ??
S/MLa 1.94 ± 0.35 3.75 ± 0.33
Differences between C group and T2 group in all parts of gastroin-
testinal tract studied are statistically significant (p B 0.05)
CML circular muscle layer, MP myenteric plexus, SP gastric sub-
mucous plexus, OSP intestinal outer submucous plexus, ISP intestinal
inner submucous plexus, S/ML submucosal/mucosal layer, CB cell
bodies, NF nerve fibers
a Average number of nerve profiles per area studied (mean ± SEM)
b Relative frequency of particular neuronal subclasses in presented
as % (mean ± SEM) of all neurons counted within the ganglia
stained for PGP 9.5 (used as pan neuronal marker). At least 500 PGP
9.5-positive cell bodies were evaluated in particular types of enteric
plexuses in each animal
c The density of intraganglionic nerve fibers positive for CART is
presented in arbitrary units
cFig. 3 Distribution pattern of nervous structures immunoreactive to
protein gene-product 9.5 (PGP 9.5)—used as pan neuronal marker
and CART in the wall of porcine stomach under physiological
conditions (a, a1) and after T2-toxin administration (b, b1);
I myenteric plexus, II two kinds of submucous plexus. CART-
positive neurons are indicated by arrows. The right column of the
pictures shows the overlap of both stainings
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in duodenum, rare (??) CART-LI intraganglionic nerves
have been observed. In descending colon, a network of
CART-LI nerve processes within OSP was denser (??)
than in the ISP, where only single such nerve fibers were
investigated (?).
The number of intramuscular CART-positive nerve
fibers was similar in both intestinal fragments studied and
slightly higher than that observed in the stomach. It
amounted to 15.99 ± 0.80 and 15.33 ± 1.77 in duodenum
(Fig. 4IIa) and descending colon (Fig. 4IIIa), respectively.
The number of CART-LI nerve fibers observed in the
intestinal mucosal layer was also higher than in the stom-
ach, but contrary to intramuscular nerves, differences
between duodenum and descending colon were noted.
Namely, in duodenum (Fig. 5IIa) this value amounted to
3.07 ± 0.14 of CART-LI nerves per observation field,
whereas in descending colon—1.94 ± 0.35 (Fig. 5IIIa).
The administration of T-2 toxin changed the percentage
of CART-LI enteric neurons, as well as the density of
nerves immunoreactive to this peptide. Generally, these
changes included a greater number of CART-LI nerve
structures, but their intensity clearly depended on the
fragment of gastrointestinal tract and part of the ENS
studied (Table 1).
The most visible increase in the percentage of CART-
positive neurons, about 25 percentage points (pp), have
been noted in duodenal myenteric (Fig. 6Ib) and outer
submucous plexuses (Fig. 6IIb), as well as in the ISP of
descending colon (above 23 pp) (Fig. 7IIIb). Slightly lower
changes were observed in the gastric MP (above 17 pp)
(Fig. 3Ib), duodenal ISP (Fig. 6IIIb), as well as colonic MP
and OSP (Fig. 7Ib, IIb) (almost 14 pp in the three men-
tioned plexuses). The smallest number of neurons
immunoreactive to CART was investigated in submucosal
plexus of the stomach, where changes amounted to about
7 pp. After T-2 toxin administration, like in control ani-
mals, two ‘‘kinds’’ of gastric submucous ganglia were
noted. The majority of them were devoid of any CART-LI
Fig. 4 Nerve fibers
immunoreactive to CART in the
circular muscle layer of the
porcine stomach (I), duodenum
(II), and descending colon (III)
under physiological conditions
(a) and after T-2 toxin
administration (b)
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neurons (Fig. 3IIb), but also ganglia with high number of
cells immunoreactive to CART were observed (Fig. 3IIb1).
In T-2 group, density of intraganglionic CART-LI nerve
fibers was also higher than in control group, but these
changes were not very clear and were observed in the
gastric MP, duodenal ISP, and all ‘‘kinds’’ of plexuses in
descending colon (Table 1).
Moreover, clear changes in the density of muscular and
mucosal CART-positive nerve fibers were observed after
T-2 toxin administration. The most visible percentage
increase was noted in duodenal muscular layer (above
10 pp) (Fig. 4IIb), whereas in other gastrointestinal frag-
ments studied, these values amounted to almost 7 pp in the
stomach (Fig. 4Ib) and about 8 pp in descending colon
(Fig. 4IIIb). Changes in the number of CART-positive
nerves in the mucosal layer (Fig. 5) were less visible and
amounted to about 5 pp in duodenum and about 2 pp
within stomach and descending colon.
Discussion
The results obtained during the present investigation show
that CART seems to be an important neuronal factor in the
enteric nervous system of porcine stomach, small and large
intestine. It is in agreement with previous studies, where
CART has been described in the ENS of many species,
including human (Ekblad 2006; Arciszewski et al. 2009;
Gonkowski et al. 2012; Zacharko-Siembida and Arcis-
zewski 2014). In the present experiment, the majority of
CART-positive neuronal structures have been observed in
myenteric plexus and circular muscle layer, what is also in
agreement with previous studies (Ekblad 2006; Gonkowski
et al. 2012; Bulc et al. 2015). On the other hand, during this
study very few population of CART-LI neurons have been
also noted within the gastric submucous plexus. This is a
clear difference from previous studies, where neurons
immunoreactive to CART have not been noted in this part
Fig. 5 Nerve fibers
immunoreactive to CART in the
mucous layer of the porcine
stomach (I), duodenum (II), and
descending colon (III) under
physiological conditions (a) and
after T-2 toxin administration
(b)
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of the ENS within the porcine stomach (Zacharko-Siem-
bida and Arciszewski 2014; Rekawek et al. 2015).
Although the presence of CART in gastric submucous
plexus seems to be compatible with observation concerning
the participation of this peptide in regulation of gastric acid
secretion (Okumura et al. 2000; Janiuk et al. 2013), the
reason of this disparity between previous studies and pre-
sent experiment is unclear. Probably, gastric porcine sub-
mucosal neurons can produce CART under various
physiological, nutritional, and/or farming factors. So, even
slight differences in feed composition, farming conditions,
and environmental bacterial flora can cause changes in
neurochemical coding of enteric neurons. The influence of
the above-mentioned factors on CART-like immunoreac-
tivity in the ENS is more presumable, because the exact
roles of this peptide in the gastrointestinal tract are still not
fully explained. Previous studies described that CART can
take part in mitigation of colon motility (Tebbe et al.
2004), reduction of gastric acid secretion, and regulation of
stomach emptying (Okumura et al. 2000; Janiuk et al.
2013; Zacharko-Siembida and Arciszewski 2014), but
mechanisms of these actions are unknown. Probably they
are realized with the use of the central nervous system,
where CART is relatively well-known factor taking part in
feeding behavior (Risold et al. 2006), because direct action
of CART on isolated fragments of the GI tract does not
change contractile or relaxational activity of intestinal
muscles (Ekblad et al. 2003). On the other hand, it is
known that CART in the enteric nervous structures co-
localizes with a wide range of neuronal active substances
(Gonkowski et al. 2013; Bulc et al. 2014), which can
suggest that this peptide plays multifold functions in
intestinal regulatory processes.
Moreover, previous studies describe that some patho-
logical factors can influence the population of CART-LI
neurons within the ENS (Gunnarsdo´ttir et al. 2007; Gon-
kowski et al. 2012, 2015), which may suggest neuropro-
tective and adaptive roles of this peptide in the digestive
system, as well as its participation in pro- or anti-inflam-
matory processes.
Also during the present study, the changes in CART-like
immunoreactivity in the porcine ENS after T-2 toxin
administration have been observed. On the one hand, this
observations show that even low doses of T-2 toxin are not
neutral for living organism and can cause changes in the
enteric nervous system. On the other hand, they confirm
that CART takes part in the pathological processes in the
GI tract. It should be pointed out that both exact reasons
and mechanisms of observed changes in CART-like
immunoreactivity are not clear and may be a result of
various factors.
Regarding the reasons of observed changes, they can be
a result of direct action of T-2 toxin on neuronal cells, and
the increase in CART-like immunoreactivity may be an
adaptive process of neurons in response to the impact of
this mycotoxin, especially the damage of mitochondria,
which has been described in previous studies (Marin et al.
2013; De Ruyck et al. 2015). On the other hand, fluctua-
tions of the number of CART-LI neuronal structures may
be connected with indirect actions of T-2 toxin, namely
with ATA—morbidity with various gastrointestinal symp-
toms, such as vomiting, diarrhea, or nausea (Lutsky and
Mor 1981; De Ruyck et al. 2015). One cannot exclude that
changes in actions of GI tract connected with the above-
mentioned symptoms, as well as inflammatory processes
accompanying ATA can be the reason of fluctuations in
CART-like immunoreactivity in the ENS, especially that
the influence of inflammation on chemical coding of
enteric neurons is relatively well known (Vasina et al.
2006).
The mechanisms of the increase in CART-LI enteric
neuronal cells number after T-2 toxin administration are
also unclear. Observed changes can be a result an aug-
mentation of CART synthesis within enteric neurons, as
well as fluctuations in molecular transport of this peptide
between cells bodies and nerve endings. Most probably,
changes in CART-like immunoreactivity noted during the
present study are caused by the increase in the synthesis of
CART in neuronal cell bodies with simultaneous intensi-
fication of molecular transport of this peptide from peri-
karya to nerve endings. This hypothesis is supported by the
fact that during the present investigation the increase in
CART-like immunoreactivity has been observed both in
enteric neuronal cell bodies and nerve fibers. In turn,
fluctuations in synthesis of CART may arise from various
changes in the transcription, translation, and/or post-
translational modification, where pro-peptide under con-
vertase enzymes transforms to biological active form of
CART (Maixnerova´ et al. 2007).
Conclusions
To sum up, the obtained results show that T-2 toxin in low
doses may affect the enteric nervous system and therefore
even suggested permissible doses in feed cannot be quali-
fied as completely safe for living organisms, what has been
suggested in previous studies (Obremski et al. 2008, 2013).
Moreover, the present study confirms that CART seems to
bFig. 6 Distribution pattern of nervous structures immunoreactive to
protein gene-product 9.5 (PGP 9.5)—used as pan neuronal marker
and CART in the wall of porcine duodenum under physiological
conditions (a) and after T-2 toxin administration (b); I myenteric
plexus, II outer submucous plexus, III inner submucous plexus.
CART-positive neurons are indicated by arrows. The right column of
the pictures shows the overlap of both stainings
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be an important neuronal factor within the enteric nervous
system, which takes part in regulation of intestinal func-
tions both in physiological conditions and during patho-
logical states. Due to the fact that the increase in CART-
like immunoreactivity has been observed during the pre-
sent study as well as in previous investigations on zear-
alenone intoxication (Gonkowski et al. 2015), and it is well
accepted that expression of neuroprotective substances
usually increases under the majority of pathological stimuli
(Arciszewski and Ekblad 2005), it can be assumed that this
peptide also plays neuroprotective roles in the ENS. On the
other hand, some previous studies on various pathological
factors (such as axotomy or inflammatory processes) have
shown the decline in CART-LI enteric neurons number
(Burlin´ski 2012; Gonkowski et al. 2012). So, the exact
functions of CART in intestinal innervation still remain not
fully explained and require further investigations.
Acknowledgments This study was supported by the University of
Warmia and Mazury in Olsztyn (statutory research) Grant No.
15.610.003-300 and KNOW (Leading National Research Centre)
Scientific Consortium ‘‘Healthy Animal – Safe Food,’’ decision of
Ministry of Science and Higher Education No. 05-1/KNOW2/2015.
Compliance with Ethical Standards
Conflict of interests The authors declare that they have no conflict of
interest.
Ethics Approval During experiment, animals were kept in standard
conditions, and all experimental actions were made in accordance
with instructions of Local Ethical Committee for Animal Experiments
in Olsztyn (Poland) (decision from 28th Nov 2012, identification code
73/2012/DTN).
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
Agrawal M, Bhaskar AS, Lakshmana Rao PV (2015) Involvement of
mitogen-activated protein kinase pathway in T-2 toxin-induced
cell cycle alteration and apoptosis in human neuroblastoma cells.
Mol Neurobiol 51(3):1379–1394
Arciszewski MB, Ekblad E (2005) Effects of vasoactive intestinal
peptide and galanin on survival of cultured porcine myenteric
neurons. Regul Pept 125:185–192
Arciszewski MB, Barabasz S, Skobowiat C, Maksymowicz W,
Majewski M (2009) Immunodetection of cocaine- and amphe-
tamine-regulated transcript in the rumen, reticulum, omasum and
abomasum of the sheep. Anat Histol Embryol 38:62–67
Bulc M, Gonkowski S, Landowski P, Kamin´ska B, Całka J (2014)
Immunohistochemical distribution of cocaine and amphetamine
regulatory peptide—like immunoreactive (CART-LI) nerve
fibers in the circular muscle layer and their relationship to other
peptides in the human caecum. Acta Histochem 116:1029–1036
Bulc M, Gonkowski S, Calka J (2015) Expression of cocaine and
amphetamine regulated transcript (CART) in the porcine intra-
mural neurons of stomach in the course of experimentally
induced diabetes mellitus. J Mol Neurosci 57:376–385
Burlin´ski PJ (2012) Inflammation- and axotomy-induced changes in
cocaine- and amphetamine-regulated transcript peptide-like
immunoreactive (CART-LI) nervous structures in the porcine
descending colon. Pol J Vet Sci 15:517–524
De Ruyck K, De Boevre M, Huybrechts I, De Saeger S (2015) Dietary
mycotoxins, co-exposure, and carcinogenesis in humans: short
review. Mutat Res Rev Mutat Res 766:32–41
Doi K, Uetsuka K (2011) Mechanisms of mycotoxin-induced
neurotoxicity through oxidative stress-associated pathways. Int
J Mol Sci 12(8):5213–5237
Ekblad E (2006) CART in the enteric nervous system. Peptides
27:2024–2030
Ekblad E, Kuhar MJ, Wierup N, Sundler F (2003) Cocaine- and
amphetamine-regulated transcript distribution and function in rat
gastrointestinal tract. Neurogastroenterol Motil 15:545–557
Ellis LM, Mawe GM (2003) Distribution and chemical coding of
cocaine- and amphetamine-regulated transcript peptide (CART)-
immunoreactive neurons in the guinea pig bowel. Cell Tissue
Res 312:265–274
Eriksen GS, Pettersson H (2004) Toxicological evaluation of
trichothecenes in animal feed. Anim Feed Sci Technol
114:205–239
Furness JB, Callaghan BP, Rivera LR, Cho HJ (2014) The enteric
nervous system and gastrointestinal innervation: integrated local
and central control. Adv Exp Med Biol 817:39–71
Gonkowski S (2013) Substance P as a neuronal factor in the enteric
nervous system of the porcine descending colon in physiological
conditions and during selected pathogenic processes. BioFactors
39:542–551
Gonkowski S, Kaminska B, Bossowska A, Korzon M, Landowski P,
Majewski M (2003) The influence of experimental Bacteroides
fragilis infection on substance P and somatostatin-immunoreac-
tive neural elements in the porcine ascending colon-a prelimi-
nary report. Folia Morphol 62:455–457
Gonkowski S, Burlinski P, Szwajca P, Calka J (2012) Changes in
cocaine- and amphetamine-regulated transcript-like immunore-
active (CART-LI) nerve structures of the porcine descending
colon during proliferative enteropathy. Bull Vet Inst Pulawy
56:199–203
Gonkowski S, Kaminska B, Landowski P, Calka J (2013) Immuno-
histochemical distribution of cocaine- and amphetamine-regu-
lated transcript peptide—like immunoreactive (CART-LI) nerve
fibers and various degree of co-localization with other neuronal
factors in the circular muscle layer of human descending colon.
Histol Histopathol 28:851–858
Gonkowski S, Obremski K, Calka J (2015) The influence of low doses
of zearalenone on distribution of selected active substances in
nerve fibers within the circular muscle layer of porcine ileum.
J Mol Neurosci 56:878–886
bFig. 7 Distribution pattern of nervous structures immunoreactive to
protein gene-product 9.5 (PGP 9.5)—used as pan neuronal marker
and CART in the wall of porcine descending colon under physiolog-
ical conditions (a) and after T-2 toxin administration (b); I myenteric
plexus, II outer submucous plexus, III inner submucous plexus.
CART-positive neurons are indicated by arrows. The right column of
the pictures shows the overlap of both stainings
146 Neurotox Res (2017) 31:136–147
123
Gunnarsdo´ttir A, Wierup N, Larsson LT, Kuhar MJ, Ekblad E (2007)
CART-peptide immunoreactivity in enteric nerves in patients
with Hirschsprung’s disease. Eur J Pediatr Surg 17:184–189
Janiuk I, Mlynek K, Wysocki J (2013) Identification and location of
the cocaine and amphetamine regulated transcript (CART) in the
abomasum of cattle. Acta Histochem 115:371–375
Lutsky I, Mor N (1981) Alimentary toxic aleukia (septic angina,
endemic panmyelotoxicosis, alimentary hemorrhagic aleukia):
t-2 toxin-induced intoxication of cats. Am J Pathol 104:189–191
Maixnerova´ J, Hlava´cek J, Blokesova´ D, Kowalczyk W, Elbert T,
Sanda M, Blechova´ M, Zelezna´ B, Slaninova´ J, Maletı´nska´ L
(2007) Structure–activity relationship of CART (cocaine- and
amphetamine-regulated transcript) peptide fragments. Peptides
28:1945–1953
Marin S, Ramos AJ, Cano-Sancho G, Sanchis V (2013) Mycotoxins:
occurrence, toxicology, and exposure assessment. Food Chem
Toxicol 60:218–237
Martin LJ, Doebler JA, Anthony A (1986) Scanning cytophotometric
analysis of brain neuronal nuclear chromatin changes in acute
T-2 toxin-treated rats. Toxicol Appl Pharmacol 15
85(2):207–214
Obremski K, Zielonka L, Gajecka M, Jakimiuk E, Bakula T,
Baranowski M, Gajecki M (2008) Histological estimation of
the small intestine wall after administration of feed containing
deoxynivalenol, T-2 toxin and zearalenone in the pig. Pol J Vet
Sci 11:339–345
Obremski K, Podlasz P, Zmigrodzka M, Winnicka A, Woz´ny M,
Brzuzan P, Jakimiuk E, Wojtacha P, Gajecka M, Zielonka L,
Gajecki M (2013) The effect of T-2 toxin on percentages of
CD4?, CD8?, CD4? CD8? and CD21? lymphocytes, and
mRNA expression levels of selected cytokines in porcine ileal
Peyer’s patches. Pol J Vet Sci 16:341–349
Okumura T, Yamada H, Motomura W, Kohgo Y (2000) Cocaine-
amphetamine-regulated transcript (CART) acts in the central
nervous system to inhibit gastric acid secretion via brain
corticotrophin-releasing factor system. Endocrinology
141:2854–2860
Rekawek W, Sobiech P, Gonkowski S, Zarczynska K, Snarska A,
Wasniewski T, Wojtkiewicz J (2015) Distribution and chemical
coding patterns of cocaine- and amphetamine-regulated tran-
script—like immunoreactive (CART-LI) neurons in the enteric
nervous system of the porcine stomach cardia. Pol J Vet Sci
18:515–522
Risold PY, Bernard-Franchi G, Collard C, Jacquemard C, La Roche
A, Griffond B (2006) Ontogenic expression of CART-peptides in
the central nervous system and the periphery: a possible
neurotrophic role? Peptides 27:1938–1941
Spiess J, Villareal J, Wale W (1981) Isolation and sequence analysis
of somatostatin-like polypeptide from ovine hypothalamus.
Biochemistry 20:1982–1988
Tebbe JJ, Ortmann E, Schumacher K, Mo¨nnikes H, Kobelt P, Arnold
R, Scha¨ffer MKH (2004) Cocaine- and amphetamine-regulated
transcript stimulates colonic motility via central CRF receptor
activation and peripheral cholinergic pathways in fed conscious
rats. Neurogastroenterol Motil 16:489–496
Vasina V, Barbara G, Talamonti L, Stanghellini V, Corinaldesi R,
Tonini M, De Ponti F, De Giorgio R (2006) Enteric neuroplasticity
evoked by inflammation. Auton Neurosci 126–127:264–272
Verma N, Rettenmeier AW, Schmitz-Spanke S (2011) Recent
advances in the use of Sus scrofa (pig) as a model system for
proteomic studies. Proteomics 11:776–793
Weidner M, Hu¨wel S, Ebert F, Schwerdtle T, Galla HJ, Humpf HU
(2013) Influence of T-2 and HT-2 toxin on the blood-brain
barrier in vitro: new experimental hints for neurotoxic effects.
PLoS One 8:e60484
Wojtkiewicz J, Ro´wniak M, Crayton R, Gonkowski S, Robak A,
Zalecki M, Majewski M, Klimaschewski L (2013) Axotomy-
induced changes in the chemical coding pattern of colon
projecting calbindin-positive neurons in the inferior mesenteric
ganglia of the pig. J Mol Neurosci 51:99–108
Zacharko-Siembida A, Arciszewski MB (2014) Immunoreactivity to
cocaine- and amphetamine-regulated transcript in the enteric
nervous system of the pig and wild boar stomach. Anat Histol
Embryol 43:48–55
Neurotox Res (2017) 31:136–147 147
123
